Woodcock, E. A., & Grubb, D. R. (2015). Novel Therapeutic Targets in Heart Failure: The Phospholipase Cβ1b-Shank3 Interface. Clinical medicine insights. Therapeutics, 2015(7), 11. https://doi.org/10.4137/CMT.S18480
Chicago Style (17th ed.) CitationWoodcock, Elizabeth A., and David R. Grubb. "Novel Therapeutic Targets in Heart Failure: The Phospholipase Cβ1b-Shank3 Interface." Clinical Medicine Insights. Therapeutics 2015, no. 7 (2015): 11. https://doi.org/10.4137/CMT.S18480.
MLA (9th ed.) CitationWoodcock, Elizabeth A., and David R. Grubb. "Novel Therapeutic Targets in Heart Failure: The Phospholipase Cβ1b-Shank3 Interface." Clinical Medicine Insights. Therapeutics, vol. 2015, no. 7, 2015, p. 11, https://doi.org/10.4137/CMT.S18480.
Warning: These citations may not always be 100% accurate.